JP2025061689A5 - - Google Patents
Info
- Publication number
- JP2025061689A5 JP2025061689A5 JP2025001906A JP2025001906A JP2025061689A5 JP 2025061689 A5 JP2025061689 A5 JP 2025061689A5 JP 2025001906 A JP2025001906 A JP 2025001906A JP 2025001906 A JP2025001906 A JP 2025001906A JP 2025061689 A5 JP2025061689 A5 JP 2025061689A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962796733P | 2019-01-25 | 2019-01-25 | |
| US62/796,733 | 2019-01-25 | ||
| JP2021543232A JP2022523052A (ja) | 2019-01-25 | 2020-01-24 | 変異型ｒａｓを標的とするための組成物および方法 |
| PCT/US2020/014988 WO2020154617A1 (en) | 2019-01-25 | 2020-01-24 | Compositions and methods for targeting mutant ras |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543232A Division JP2022523052A (ja) | 2019-01-25 | 2020-01-24 | 変異型ｒａｓを標的とするための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025061689A JP2025061689A (ja) | 2025-04-11 |
| JP2025061689A5 true JP2025061689A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2025-08-14 |
Family
ID=71735822
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543232A Pending JP2022523052A (ja) | 2019-01-25 | 2020-01-24 | 変異型ｒａｓを標的とするための組成物および方法 |
| JP2025001906A Pending JP2025061689A (ja) | 2019-01-25 | 2025-01-06 | 変異型ｒａｓを標的とするための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543232A Pending JP2022523052A (ja) | 2019-01-25 | 2020-01-24 | 変異型ｒａｓを標的とするための組成物および方法 |
Country Status (9)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022521513A (ja) * | 2019-02-20 | 2022-04-08 | フレッド ハッチンソン キャンサー リサーチ センター | Ｒａｓネオ抗原に特異的な結合タンパク質およびその使用 |
| US11058751B1 (en) | 2020-11-20 | 2021-07-13 | Think Therapeutics, Inc. | Compositions for optimized RAS peptide vaccines |
| US11421015B2 (en) | 2020-12-07 | 2022-08-23 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
| CN116710115A (zh) | 2020-11-20 | 2023-09-05 | 思维疗法股份有限公司 | 用于优化的肽疫苗的组合物和方法 |
| AU2022227029A1 (en) * | 2021-02-26 | 2023-08-31 | New York University | Compositions and methods comprising antibodies that bind to covalent peptide conjugates |
| US11464842B1 (en) | 2021-04-28 | 2022-10-11 | Think Therapeutics, Inc. | Compositions and method for optimized peptide vaccines using residue optimization |
| AU2022283277A1 (en) * | 2021-05-25 | 2023-12-14 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting ras mutations and uses thereof |
| CA3235177A1 (en) * | 2021-10-28 | 2023-05-04 | Genentech, Inc. | Systems and methods to identify mhc-associated antigens for therapeutic intervention |
| WO2023175069A1 (en) * | 2022-03-16 | 2023-09-21 | Medigene Immunotherapies Gmbh | Tcr constant region pairing library for pramevld tcrs |
| WO2023175070A1 (en) * | 2022-03-16 | 2023-09-21 | Medigene Immunotherapies Gmbh | Tcr constant region pairing library |
| CN120091826A (zh) * | 2022-08-12 | 2025-06-03 | 阿巴塔治疗股份有限公司 | 多发性硬化症的细胞疗法 |
| KR20240102892A (ko) * | 2022-12-23 | 2024-07-03 | 한미약품 주식회사 | 복수 kras 변이 펩티드가 연결된 항원 펩티드, 이를 코딩하는 핵산 및 이의 용도 |
| WO2024148183A2 (en) * | 2023-01-04 | 2024-07-11 | Board Of Regents, The University Of Texas System | T cell receptors targeting the highly prevalent kras g12v mutation on hla-a*03:01 in lung cancer |
| IL304887A (en) * | 2023-07-31 | 2025-02-01 | Yeda Res & Dev | T-cell receptor directed against RAS neoantigen |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997040156A1 (en) * | 1996-04-19 | 1997-10-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
| WO2015123532A1 (en) * | 2014-02-16 | 2015-08-20 | Globeimmune, Inc. | Ras g12r immunotherapy for ras mutation-positive cancers |
| CN106459924A (zh) * | 2014-04-23 | 2017-02-22 | 得克萨斯州大学系统董事会 | 用于疗法中的嵌合抗原受体(car)及其制备方法 |
| JP6863893B2 (ja) * | 2014-11-26 | 2021-04-21 | アメリカ合衆国 | 抗突然変異ｋｒａｓ ｔ細胞受容体 |
| GB201516277D0 (en) * | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR libraries |
| EP3394092A1 (en) * | 2015-12-23 | 2018-10-31 | Fred Hutchinson Cancer Research Center | High affinity t cell receptors and uses thereof |
| AU2017306038B2 (en) * | 2016-08-02 | 2023-06-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-KRAS-G12D T cell receptors |
| MA50180A (fr) * | 2017-09-20 | 2021-05-26 | Us Health | Récepteurs de lymphocytes t restreints au hla de classe ii contre kras muté |
| EA202091335A1 (ru) * | 2017-12-04 | 2020-10-15 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Ограниченные hla класса i t-клеточные рецепторы против мутантного ras |
| WO2019112932A1 (en) * | 2017-12-04 | 2019-06-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of enriching cell populations for cancer-specific t cells using in vitro stimulation of memory t cells |
| EP3837279A4 (en) * | 2018-08-16 | 2022-05-11 | BioNTech US Inc. | T-CELL RECEPTOR CONSTRUCTS AND USES THEREOF |
| JP2022521513A (ja) * | 2019-02-20 | 2022-04-08 | フレッド ハッチンソン キャンサー リサーチ センター | Ｒａｓネオ抗原に特異的な結合タンパク質およびその使用 |
| CN112646024B (zh) * | 2019-10-10 | 2023-03-24 | 香雪生命科学技术（广东）有限公司 | 一种识别kras突变的t细胞受体及其编码序列 |
| AU2020384374A1 (en) * | 2019-11-15 | 2022-06-09 | Seattle Project Corp. | Antigen-binding proteins targeting shared neoantigens |
| CN117957015A (zh) * | 2021-09-17 | 2024-04-30 | 磨石生物公司 | Kras新抗原疗法 |
-
2020
- 2020-01-24 AU AU2020213119A patent/AU2020213119A1/en active Pending
- 2020-01-24 SG SG11202108039QA patent/SG11202108039QA/en unknown
- 2020-01-24 EP EP20745784.7A patent/EP3914270A4/en active Pending
- 2020-01-24 JP JP2021543232A patent/JP2022523052A/ja active Pending
- 2020-01-24 CA CA3127673A patent/CA3127673A1/en active Pending
- 2020-01-24 KR KR1020217026690A patent/KR20210119468A/ko active Pending
- 2020-01-24 CN CN202080024782.6A patent/CN113631172A/zh active Pending
- 2020-01-24 WO PCT/US2020/014988 patent/WO2020154617A1/en not_active Ceased
- 2020-01-24 US US17/425,498 patent/US20220088190A1/en active Pending
-
2025
- 2025-01-06 JP JP2025001906A patent/JP2025061689A/ja active Pending